News
CSBR
--
0.00%
--
Champions Oncology Q1 EPS $0.01, Inline, Sales $11.30M Beat $10.97M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $11.30
Benzinga · 3d ago
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced its financial results for its first quarter of fiscal 2022, ended July 31, 2021.
ACCESSWIRE · 3d ago
Champions Oncology, Inc. (CSBR) Reports Q1 Loss, Tops Revenue Estimates
Zacks.com · 3d ago
Earnings Scheduled For September 13, 2021
  Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third quarter.
Benzinga · 3d ago
Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect
Zacks.com · 09/06 19:00
What Kind Of Shareholders Hold The Majority In Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares?
A look at the shareholders of Champions Oncology, Inc. ( NASDAQ:CSBR ) can tell us which group is most powerful...
Simply Wall St. · 09/06 11:09
5 Buy-Rated Small-Cap Biotech Stocks to Add to Your Watchlist
StockNews.com · 09/03 13:44
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and development will report its financial and operational results for the first quarter end...
ACCESSWIRE · 09/02 20:30
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative pharmacology, biomarker, and data platforms, announced toda...
ACCESSWIRE · 07/26 12:31
BRIEF-Champions Biotechnology Says Q4 Revenue Increased 21% To $10.6 Mln
reuters.com · 07/22 13:08
Champions Oncology beats on revenue
Champions Oncology (CSBR): Q4 Non-GAAP EPS of -$0.03; GAAP EPS of -$0.04.Revenue of $10.6M (+20.5% Y/Y) beats by $0.57M.Press Release
Seekingalpha · 07/22 12:48
Champions Oncology Reports Quarterly Revenue of $10.6 Million
ACCESSWIRE · 07/22 12:00
-- Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Reports Q4 Loss $-0.03
MT Newswires · 07/22 08:11
Earnings Scheduled For July 22, 2021
  Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter.
Benzinga · 07/22 08:02
2 Top Biotech Stocks to Buy Under $10
StockNews.com · 07/15 09:39
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative pharmacology, biomarker and data platforms, today announ...
ACCESSWIRE · 07/14 12:30
The Champions Oncology (NASDAQ:CSBR) Share Price Is Up 335% And Shareholders Are Delighted
While Champions Oncology, Inc. ( NASDAQ:CSBR ) shareholders are probably generally happy, the stock hasn't had...
Simply Wall St. · 07/08 07:06
Champions Oncology And BGI Americas Announce Partnership To Provide Mass Spectrometry Proteomics, Metabolomics, And Multi-Omic Data Analysis Solutions
Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI Americas. Through this partnership, BGI will now have access
Benzinga · 06/15 13:04
Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions
HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI Americas.Through this partnership, BGI will now have acc...
ACCESSWIRE · 06/15 13:00
Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Simply Wall St. · 04/29 07:31
Webull provides a variety of real-time CSBR stock news. You can receive the latest news about Champions through multiple platforms. This information may help you make smarter investment decisions.
About CSBR
Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company’s TumorGraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The Company uses this technology, in conjunction with related services, to offer solutions for two consumer groups: Translational Oncology Solutions (TOS) and Personalized Oncology Solutions (POS). The Company’s TOS business offers a technology platform to pharmaceutical and biotechnology companies using TumorGraft studies. POS assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The Company subsidiaries include Champions Oncology (Israel) and Limited and Champions Biotechnology U.K., Limited.